针对近期经历自杀危机的严重心理健康问题患者提供简短远程心理社会干预的自适应多臂多阶段(MAMS)随机对照试验研究方案:远程心理社会干预实施(RAPID)
本研究为多阶段多臂随机对照试验,在五个英国站点纳入近期经历自杀危机的严重心理健康问题患者,比较三种远程心理社会干预与常规治疗。主要结局为6个月内任何精神科住院;阶段1包含内部预试验,因独立随机对照试验疗效数据已移除BrighterSide臂并调整随机化比例,预期总样本量1064例(含BrighterSide参与者为1118例)。
要点
- 主要结局为6个月内任何精神科住院,同时评估自杀想法与行为、希望、康复、焦虑和抑郁。
- 三种远程干预为期3个月:结构化同伴支持(PREVAIL)、助理心理师实施的安全计划(SAFETEL)、智能手机CBT自杀预防应用(BrighterSide)。
- 因独立随机对照试验疗效数据已移除BrighterSide臂,随机化比例调整为2:2:3(含TAU),中期分析使用前385例6个月结局数据。
核心结论
- 迫切需要基于证据的干预以减少自杀倾向从而降低精神科住院,远程提供简短心理社会干预可显著推进治疗选择。
研究设计与样本
- 多阶段多臂随机对照试验,共四臂,分两阶段进行,在五个英国站点招募近期经历自杀危机的严重心理健康问题患者。
- 阶段1包含内部预试验并设有先验进展标准;随机化通过独立远程网络系统采用随机置换区组,按站点分层。
- 阶段1随机化比例为1:1:1:2(含TAU),后因独立随机对照试验疗效数据释放而移除BrighterSide臂,调整为2:2:3(含TAU)。
- 若阶段2某臂因缺乏获益被剔除,后续参与者分配比例为1:1;预期总样本量1064例(含BrighterSide参与者为1118例)。
- 中期分析使用来自PREVAIL、SAFETEL和TAU的前385例参与者6个月结局数据。
关键数值与推荐
- 主要结局为6个月期间任何精神科住院。
- 次要评估包括自杀想法与行为、希望、康复、焦虑和抑郁。
- 三种远程干预均为期3个月:结构化同伴支持(PREVAIL)、助理心理师实施的安全计划(SAFETEL)、通过智能手机访问的CBT自杀预防应用(BrighterSide)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with serious mental health problems (SMHP) are more likely to be admitted to psychiatric hospital following contact with crisis services. Admissions can have significant personal costs, be traumatic and are the most expensive form of mental health care. There is an urgent need for treatments to reduce suicidal thoughts and behaviours and reduce avoidable psychiatric admissions. METHODS: A multi-stage, multi-arm (MAMS) randomised controlled trial (RCT) with four arms conducted over two stages to determine the clinical and cost effectiveness of three psychosocial treatments, compared to treatment as usual (TAU), for people with SMHP who have had recent suicidal crisis. Primary outcome is any psychiatric hospital admissions over a 6-month period. We will assess the impact on suicidal thoughts and behaviour, hope, recovery, anxiety and depression. The remote treatments delivered over 3 months are structured peer support (PREVAIL); a safety planning approach (SAFETEL) delivered by assistant psychologists; and a CBT-based suicide prevention app accessed via a smartphone (BrighterSide). Recruitment is at five UK sites. Stage 1 includes an internal pilot with a priori progression criteria. In stage 1, the randomisation ratio was 1:1:1:2 in favour of TAU. This has been amended to 2:2:3 in favour of TAU following an unplanned change to remove the BrighterSide arm following the release of efficacy data from an independent RCT. Randomisation is via an independent remote web-based randomisation system using randomly permuted blocks, stratified by site. An interim analysis will be performed using data from the first 385 participants from PREVAIL, SAFETEL and TAU with outcome data at 6 months. If one arm is dropped for lack of benefit in stage 2, the allocation ratio of future participants will be 1:1. The expected total sample size is 1064 participants (1118 inclusive of BrighterSide participants). DISCUSSION: There is a need for evidence-based interventions to reduce psychiatric admissions, via reduction of suicidality. Our focus on remote delivery of established brief psychosocial interventions, utilisation of different modalities of delivery that can provide sustainable and scalable solutions, which are also suitable for a pandemic or national crisis context, will significantly advance treatment options. TRIAL REGISTRATION: ISRCTN33079589. Registered on June 20, 2022.
引用
- Pyle M, Loftus L, Emsley R, et al. Study protocol for an adaptive, multi-arm, multi-stage (MAMS) randomised controlled trial of brief remotely delivered psychosocial interventions for people with serious mental health problems who have experienced a recent suicidal crisis: Remote Approaches to Psychosocial Intervention Delivery (RAPID). Trials. 2024. PMID: 38971788. doi:10.1186/s13063-024-08293-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。